Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7741-0.0061 (-0.78%)
At close: 04:00PM EDT
0.7951 +0.02 (+2.71%)
After hours: 06:07PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-113,724
-113,724
-250,157
-65,578
-89,127
Depreciation & amortisation
6,243
6,243
6,629
5,947
6,578
Stock-based compensation
34,101
34,101
25,482
20,222
8,824
Change in working capital
-58,977
-58,977
-18,391
41,530
-23,197
Accounts receivable
0
0
0
9,387
-7,602
Inventory
-29,647
-29,647
0
0
-
Accounts payable
-11,578
-11,578
2,203
9,362
-1,159
Other working capital
-125,329
-125,329
-238,637
-2,878
-94,201
Other non-cash items
15,168
15,168
6,933
4,069
2,866
Net cash provided by operating activities
-117,354
-117,354
-228,816
6,688
-93,610
Cash flows from investing activities
Investments in property, plant and equipment
-7,975
-7,975
-9,821
-9,566
-591
Purchases of investments
-4,426
-4,426
-48,221
-95,971
-218,284
Sales/maturities of investments
22,983
22,983
140,470
169,625
59,984
Net cash used for investing activities
10,582
10,582
82,428
64,088
-158,891
Cash flows from financing activities
Debt repayment
-52,860
-52,860
-1,907
-948
0
Common stock issued
18,159
18,159
101,168
0
268,641
Common stock repurchased
-
-
-
-
0
Other financing activities
-
-
-
-
19,900
Net cash used provided by (used for) financing activities
71,705
71,705
129,602
1,178
303,424
Net change in cash
-35,067
-35,067
-16,786
71,954
50,923
Cash at beginning of period
171,215
171,215
188,002
116,049
65,126
Cash at end of period
136,150
136,150
171,215
188,002
116,049
Free cash flow
Operating cash flow
-117,354
-117,354
-228,816
6,688
-93,610
Capital expenditure
-7,975
-7,975
-9,821
-9,566
-591
Free cash flow
-125,329
-125,329
-238,637
-2,878
-94,201